Neuren Pharmaceuticals | NEU - Trade Creditors

Stock Price
12.58
Daily Change
-0.42 -3.23%
Monthly
-1.33%
Yearly
31.45%
Q2 Forecast
11.77

Neuren Pharmaceuticals reported AUD2.4M in Trade Creditors for its fiscal semester ending in December of 2025.





Trade Creditors Change Date
Akebia Therapeutics USD 21.18M 11.1M Dec/2025
Alaunos Therapeutics USD 843K 34K Sep/2025
Avita Medical AUD 8.96M 1.69M Dec/2025
Clinuvel Pharmaceuticals AUD 10.68M 731.35K Dec/2025
Dianthus Therapeutics USD 9.72M 3.02M Dec/2025
Genetic Signatures AUD 3.63M 1.25M Dec/2025
Ionis Pharmaceuticals USD 14.33M 8.47M Sep/2025
Medical Developments International AUD 4.31M 2.18M Dec/2025
Neuren Pharmaceuticals AUD 2.4M 4.26M Dec/2025
Organon & Co USD 1.07B 7M Sep/2025
Paradigm Biopharmaceuticals AUD 4.44M 1.71M Dec/2025
PYC Therapeutics AUD 9.56M 802.76K Dec/2025
Starpharma Holdings AUD 2.67M 618K Dec/2025
Tectonic Therapeutic USD 1.09M 392K Dec/2025
Telix Pharmaceuticals AUD 71.66M 19.98M Dec/2025
Viatris USD 1.33B 6.4M Sep/2025
Xeris Pharmaceuticals USD 3.08M 3.45M Dec/2025